HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with better graft and patient survival among kidney transplant recipients with diabetes, according to a study ...

Significantly more patients receiving baricitinib 2 mg, 4 mg had SALT score ≤20, ≤10 versus placebo at week 36 ...

Increased risk seen for adverse cardiovascular events, including myocardial infarction, stroke, heart failure, mortality ...

HealthDay News — Adequate breastfeeding (BF) and avoidance of sugary beverages in early life may reduce the risk for preadolescent obesity in infants exposed to gestational diabetes (GDM), according ...

Model included BMI, first-degree relative family history of CRC, other family history of CRC, tobacco use as factors ...

The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of severe hypoglycemia in ...

Venxxiva ™ (tiopronin delayed-release tablet) has been made available for the treatment of cystinuria.

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium.  Arbli, an angiotensin II receptor ...

Vimkunya™ (chikungunya vaccine, recombinant) is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years ...

The active ingredient in Zunveyl is benzgalantamine, a prodrug of galantamine, a competitive and reversible inhibitor of actylcholinesterase.

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...

Daridorexant, a dual orexin receptor antagonist, is currently approved for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.